Genes linked to Alzheimer’s risk have been identified
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
List view / Grid view
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
A research team has developed a method for regenerating old brain stem cells from rat models, which could be used to treat age-related brain diseases.
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
Researchers have discovered the mechanism behind the spread of Leishmania, indicating a potential drug target.
New findings show that the environment for pancreatic cancers plays a role in its metastasis, revealing a new potential drug target.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
A chaperone protein has been identified as a possible therapeutic target for the treatment of Kennedy's disease and prostate cancer.
Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
A novel nano-vaccine has been developed which has proven effective in treating primary tumours and metastases that result from melanoma.
A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.
The first genetically modified mini human livers have been grown in a laboratory, to emulate liver disease progression and test therapeutics.
A combination of heart cells derived from human stem cells could lead to developing a treatment for heart failure.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.